| Product ID |
Product Name |
CAS# |
Purity |
| Y3267943 |
a-Amylase-IN-3 |
93944-58-2 |
99% |
| Y3294888 |
PF-06815345 hydrochloride |
2334434-49-8 |
98% |
| Y3289417 |
PRMT5-IN-29 |
2242788-69-6 |
98% |
| Y3257932 |
(S)-Osanetant |
182621-58-5 |
99.25% |
| Y3286663 |
ALOX15-IN-2 |
2764818-23-5 |
99% |
| Y3294332 |
JO146 |
130727-21-8 |
98% |
| Y3255306 |
GPR84 antagonist 2 |
2244269-74-5 |
99.53% |
| Y3268209 |
3-Bromo-4-fluoro-5-hydroxybenzoic acid |
1628539-98-9 |
95% |
| Y3294884 |
EM127 |
1886879-71-5 |
98% |
| Y3118054 |
Ulonivirine |
1591823-76-5 |
98% |
| Y3118067 |
PARP10-IN-2 |
1042780-52-8 |
98% |
| Y3295349 |
1-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-oic acid |
2138440-78-3 |
98% |
| Y3261018 |
SC209 |
1977557-86-0 |
99% |
| Y3264960 |
VU6019650 |
2926782-31-0 |
98.61% |
| Y3270081 |
Gü2602 |
1627094-88-5 |
98% |
| Y3260145 |
ZZL-7 |
99141-91-0 |
98.92% |
| Y3262192 |
4-(2-Methoxyethyl)tetrahydro-2h-pyran-4-carboxylic acid |
1310224-13-5 |
95% |
| Y3289323 |
BAY-390 |
2741956-55-6 |
98% |
| Y3265297 |
CDK12-IN-5 |
2651200-35-8 |
99% |
| Y3304656 |
Bim-IN-1 |
2909483-36-7 |
99% |
| Y3295480 |
PCAF-IN-1 |
2439194-86-0 |
98% |
| Y3286661 |
BMS-986121 |
313671-26-0 |
98% |
| Y3309487 |
1-(2,4-Dimethylphenyl)prop-2-en-1-ol |
860590-73-4 |
95% |
| Y3308949 |
Cholecystokinin |
9011-97-6 |
99% |
| Y3290305 |
RdRP-IN-2 |
2863657-16-1 |
99% |
| Y3288402 |
Emzeltrectinib |
2223678-97-3 |
99% |
| Y3268409 |
SN38-COOH |
2170118-23-5 |
98.85% |
| Y3297461 |
Aß/tau aggregation-IN-3 |
1210750-32-5 |
99% |
| Y3271315 |
Di-4-ANEPPDHQ |
797785-10-5 |
99.00% |
| Y3286920 |
Cereblon inhibitor 2 |
2639380-62-2 |
98% |
| Y3266862 |
PI3K-IN-31 |
1359956-12-9 |
99.55% |
| Y3289625 |
Rohinitib |
1139253-73-8 |
99% |
| Y3267252 |
CellTracker Blue CMF2HC Dye |
215868-45-4 |
99.78% |
| Y3271516 |
Culmerciclib maleate |
2197922-55-5 |
99.52% |
| Y3315674 |
tert-Butyl (S)-2-(hydroxymethyl)-4-methylpiperazine-1-carboxylate |
1312755-68-2 |
98% |
| Y3268276 |
diMal-O-CH2COOH |
1620837-47-9 |
95% |
| Y3306644 |
EAPB 02303 |
1958290-51-1 |
99% |
| Y3294975 |
Alpha-Guanosine |
15398-66-0 |
95% |
| Y3306502 |
MODAG-001 |
2648041-72-7 |
98% |
| Y3118065 |
Tyrosinase-IN-2 |
180864-33-9 |
98% |
| Y3293606 |
PDE4B-IN-3 |
2819779-01-4 |
99% |
| Y3286567 |
Ogremorphin |
352563-21-4 |
99% |
| Y3271109 |
Rufinamide-d2 |
1129491-38-8 |
95% |
| Y3104671 |
TP-030-2 |
2095514-84-2 |
98% |
| Y3104868 |
2-Amino-N-(4-methylthiazol-2-yl)-2-phenylacetamide |
888-47-1 |
95% |
| Y3104719 |
XMT-1519 conjugate-1 |
2720500-19-4 |
98% |
| Y3293669 |
HPK1-IN-26 |
2229042-24-2 |
98% |
| Y3104881 |
SPEN-IN-1 |
2863686-82-0 |
98.47% |
| Y3294486 |
Benzyl DC-81 |
127810-79-1 |
98% |
| Y3104752 |
PFM03 |
1558598-48-3 |
98% |
| Y3104763 |
Naringenin-d4 |
1192260-78-8 |
98.0% |
| Y3292347 |
EGFR-IN-70 |
2926716-96-1 |
99% |
| Y3104759 |
(1-(4-(Difluoromethoxy)phenyl)cyclopropyl)methanamine |
1037131-62-6 |
95% |
| Y3104743 |
SY-LB-57 |
2253719-35-4 |
99% |
| Y3294047 |
Fazamorexant |
1808918-69-5 |
99% |
| Y3293424 |
IRAK4-IN-22 |
2170694-05-8 |
98% |
| Y3286751 |
EGGGG-PEG8-amide-bis(deoxyglucitol) |
2842855-38-1 |
98% |
| Y3310001 |
1-Bromo-3-fluoro-2-methoxy-4-nitrobenzene |
1224629-07-5 |
95% |
| Y3270472 |
Bisdemethoxycurcumin-d8 |
2470233-08-8 |
98% |
| Y3297422 |
Z16078526 |
852222-94-7 |
98% |
| Y3258301 |
Bleximenib oxalate |
2866179-95-3 |
98% |
| Y3272600 |
Mtb ATP synthase-IN-1 |
2642394-38-3 |
98.55% |
| Y3296654 |
PqsR/LasR-IN-3 |
2581109-51-3 |
99% |
| Y3118038 |
Haspin-IN-3 |
2416569-95-2 |
98% |
| Y3293105 |
WU-FA-01 |
882429-53-0 |
95% |
| Y3255309 |
PI3Ka-IN-11 |
300803-79-6 |
95.35% |
| Y3296924 |
HDAC6 degrader-1 |
2439058-23-6 |
98% |
| Y3295241 |
NLRP3-IN-17 |
2254432-75-0 |
99% |
| Y3290117 |
Zilucoplan |
1841136-73-9 |
95% |
| Y3298021 |
BLU2864 |
2810747-89-6 |
99% |
| Y3290884 |
MK-8189 |
1424371-93-6 |
99% |
| Y3304666 |
GSK3735967 |
2170136-86-2 |
99% |
| Y3308370 |
BAY-805 |
2925481-88-3 |
99% |
| Y3258290 |
Dyrk1A-IN-5 |
1685235-41-9 |
98% |
| Y3287499 |
3-(1-Methyl-1h-pyrazol-5-yl)propan-1-ol |
1342565-73-4 |
95% |
| Y3261408 |
NJH-2-056 |
2858812-69-6 |
98.23% |
| Y3261774 |
ALK5-IN-8 |
2705900-81-6 |
98.06% |
| Y3261776 |
Glucosylceramide synthase-IN-1 |
2601393-20-6 |
99% |
| Y3291343 |
QTZ |
2883232-39-9 |
96% |
| Y3258623 |
Enpp/Carbonic anhydrase-IN-1 |
2883495-35-8 |
99% |
| Y3290401 |
SARS-CoV-2 3CLpro-IN-2 |
2765088-93-3 |
99% |
| Y3259894 |
Dermaseptin TFA |
646451-06-1 |
99% |
| Y3264152 |
SY-LB-35 |
2603461-70-5 |
98% |
| Y3288318 |
ALOX15-IN-1 |
2764818-24-6 |
98% |
| Y3291294 |
SRT 1720 dihydrochloride |
2468639-77-0 |
99% |
| Y3117823 |
Benzyl (5S)-5-methyl-1,4-diazepane-1-carboxylate |
1001401-61-1 |
97% |
| Y3117784 |
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)picolinaldehyde |
1908436-02-1 |
98% |
| Y3261512 |
eIF4A3-IN-14 |
1402931-65-0 |
99% |
| Y3117881 |
2,6-Difluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol |
2756163-62-7 |
95% |
| Y3296284 |
MMP-7-IN-1 |
2865097-05-6 |
99% |
| Y3291026 |
MDH1-IN-1 |
2143463-31-2 |
99% |
| Y3294566 |
SOS1-IN-15 |
2793404-47-2 |
99% |
| Y3297579 |
FD-1080 free acid |
1151888-25-3 |
97% |
| Y3293852 |
NVOC cage-TMP-Halo |
2137894-98-3 |
96% |
| Y3286554 |
E-3620 |
151213-86-4 |
98% |
| Y3306641 |
SLC26A3-IN-2 |
950348-60-4 |
98% |
| Y3118057 |
ML162-yne |
2883115-46-4 |
98% |
| Y3306666 |
FLT3-IN-19 |
2237234-48-7 |
99% |
| Y3268640 |
ATG7-IN-2 |
2226227-75-2 |
99% |
| Y3262504 |
TMX-4113 |
2766385-92-4 |
98.66% |